novofem 1 mg / 1 mg
novo nordisk a/s - Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 1 mg / 1 mg
sequidot 50 mikrog / 250 mikrog
sandoz a/s - Østradiolhemihydrat / noretisteronacetat - depotplaster - 50 mikrog / 250 mikrog
trisekvens -
novo nordisk a/s - Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 2 mg / 1 mg
femoston 2 mg / 10 mg
viatris healthcare ltd. - Østradiolhemihydrat / dydrogesteron - tablett, filmdrasjert - 2 mg / 10 mg
femoston 1 mg / 10 mg
viatris healthcare ltd. - Østradiolhemihydrat / dydrogesteron - tablett, filmdrasjert - 1 mg / 10 mg
willfact 1000 ie
lfb biomedicaments - von willebrandfaktor (human) - pulver og væske til injeksjonsvæske, oppløsning - 1000 ie
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemoragika - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
bettamousse 1 mg/ g
rph pharmaceuticals ab - betametasonvalerat - skum - 1 mg/ g
sonazoid 8 mikroliter/ ml
ge healthcare as - perflubutan - pulver og væske til injeksjonsvæske, dispersjon - 8 mikroliter/ ml
takrozem 0.1 %
pierre fabre dermatologie - takrolimus - salve - 0.1 %